Research
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey
Paul Arora, Priya Vasa, Darren Brenner, Karl Iglar, Phil McFarlane, Howard Morrison and Alaa Badawi
CMAJ June 11, 2013 185 (9) E417-E423; DOI: https://doi.org/10.1503/cmaj.120833
Paul Arora
From the Division of Science and Technology, Laboratory for Foodborne Zoonoses (Arora, Badawi), Public Health Agency of Canada, Toronto, Ont.; the Division of Epidemiology (Arora, Brenner), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; the Department of Family and Community Medicine (Vasa), University of Toronto, Toronto, Ont.; the Departments of Family and Community Medicine (Vasa, Iglar) and Medicine (McFarlane), St. Michael’s Hospital, Toronto, Ont.; and the Science Integration Division, Social Determinants and Science Integration Directorate, Health Promotion and Chronic Disease Prevention Branch (Morrison), Public Health Agency of Canada, Ottawa, Ont.
Priya Vasa
From the Division of Science and Technology, Laboratory for Foodborne Zoonoses (Arora, Badawi), Public Health Agency of Canada, Toronto, Ont.; the Division of Epidemiology (Arora, Brenner), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; the Department of Family and Community Medicine (Vasa), University of Toronto, Toronto, Ont.; the Departments of Family and Community Medicine (Vasa, Iglar) and Medicine (McFarlane), St. Michael’s Hospital, Toronto, Ont.; and the Science Integration Division, Social Determinants and Science Integration Directorate, Health Promotion and Chronic Disease Prevention Branch (Morrison), Public Health Agency of Canada, Ottawa, Ont.
Darren Brenner
From the Division of Science and Technology, Laboratory for Foodborne Zoonoses (Arora, Badawi), Public Health Agency of Canada, Toronto, Ont.; the Division of Epidemiology (Arora, Brenner), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; the Department of Family and Community Medicine (Vasa), University of Toronto, Toronto, Ont.; the Departments of Family and Community Medicine (Vasa, Iglar) and Medicine (McFarlane), St. Michael’s Hospital, Toronto, Ont.; and the Science Integration Division, Social Determinants and Science Integration Directorate, Health Promotion and Chronic Disease Prevention Branch (Morrison), Public Health Agency of Canada, Ottawa, Ont.
Karl Iglar
From the Division of Science and Technology, Laboratory for Foodborne Zoonoses (Arora, Badawi), Public Health Agency of Canada, Toronto, Ont.; the Division of Epidemiology (Arora, Brenner), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; the Department of Family and Community Medicine (Vasa), University of Toronto, Toronto, Ont.; the Departments of Family and Community Medicine (Vasa, Iglar) and Medicine (McFarlane), St. Michael’s Hospital, Toronto, Ont.; and the Science Integration Division, Social Determinants and Science Integration Directorate, Health Promotion and Chronic Disease Prevention Branch (Morrison), Public Health Agency of Canada, Ottawa, Ont.
Phil McFarlane
From the Division of Science and Technology, Laboratory for Foodborne Zoonoses (Arora, Badawi), Public Health Agency of Canada, Toronto, Ont.; the Division of Epidemiology (Arora, Brenner), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; the Department of Family and Community Medicine (Vasa), University of Toronto, Toronto, Ont.; the Departments of Family and Community Medicine (Vasa, Iglar) and Medicine (McFarlane), St. Michael’s Hospital, Toronto, Ont.; and the Science Integration Division, Social Determinants and Science Integration Directorate, Health Promotion and Chronic Disease Prevention Branch (Morrison), Public Health Agency of Canada, Ottawa, Ont.
Howard Morrison
From the Division of Science and Technology, Laboratory for Foodborne Zoonoses (Arora, Badawi), Public Health Agency of Canada, Toronto, Ont.; the Division of Epidemiology (Arora, Brenner), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; the Department of Family and Community Medicine (Vasa), University of Toronto, Toronto, Ont.; the Departments of Family and Community Medicine (Vasa, Iglar) and Medicine (McFarlane), St. Michael’s Hospital, Toronto, Ont.; and the Science Integration Division, Social Determinants and Science Integration Directorate, Health Promotion and Chronic Disease Prevention Branch (Morrison), Public Health Agency of Canada, Ottawa, Ont.
Alaa Badawi
From the Division of Science and Technology, Laboratory for Foodborne Zoonoses (Arora, Badawi), Public Health Agency of Canada, Toronto, Ont.; the Division of Epidemiology (Arora, Brenner), Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.; the Department of Family and Community Medicine (Vasa), University of Toronto, Toronto, Ont.; the Departments of Family and Community Medicine (Vasa, Iglar) and Medicine (McFarlane), St. Michael’s Hospital, Toronto, Ont.; and the Science Integration Division, Social Determinants and Science Integration Directorate, Health Promotion and Chronic Disease Prevention Branch (Morrison), Public Health Agency of Canada, Ottawa, Ont.

Article Figures & Tables
Tables
- Table 1:
Demographic characteristics of survey participants (n = 3689*)
- Table 3:
Age-standardized, weighted prevalence of risk factors for cardiovascular events and progression of chronic kidney disease among Canadian adults without a self-reported heart condition
- Table 4:
Proportion of adults with and without albuminuria, by estimated glomerular filtration rate (eGFR) group
In this issue
Article tools
Respond to this article
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey
Paul Arora, Priya Vasa, Darren Brenner, Karl Iglar, Phil McFarlane, Howard Morrison, Alaa Badawi
CMAJ Jun 2013, 185 (9) E417-E423; DOI: 10.1503/cmaj.120833
Jump to section
Related Articles
Cited By...
- Assessment of medication Dosage Adjustment in Hospitalized Patients with Chronic Kidney Disease
- Impact of the KidneyWise toolkit on chronic kidney disease referral practices in Ontario primary care: a prospective evaluation
- Kidney Health Strategic Clinical Network: Driving positive change to optimize kidney health in Alberta
- Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
- Draw me your disease: Obstacles to palliative intervention for patients with noncancer diagnoses
- Dessine-moi ta maladie: Les obstacles a lintegration palliative pour les patients non cancereux
- Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study
- Approach to the detection and management of chronic kidney disease: What primary care providers need to know
- Inorganic phosphate as a potential risk factor for chronic disease
- Kidney age, not kidney disease
- A Population-Based Analysis of Quality Indicators in CKD
- Evaluation of a mentorship program to support chronic kidney disease care
- The See Kidney Disease Targeted Screening Program for CKD
- Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD
- Retroperitoneal haematoma associated with enoxaparin use in an elderly woman with chronic kidney disease